Introduction
For centuries, biologists have marveled at the ability of organisms such as salamanders to regrow near perfect copies of amputated body parts through a precisely orchestrated process called epimorphic regeneration. Epimorphic regeneration occurs via the formation of a blastema, a mass of undifferentiated and differentiated cells containing a heterogeneous pool of progenitor cells. The few mammalian tissues which are capable of regenerating, such as blood, skeletal muscle and epithelium, renew predominantly through stem cells, instead of forming a blastema. However, stem cell-based regeneration has not proven widely effective for most tissues plagued by degenerative processes such as the heart and nervous system.(1) We tried to describe a better understanding about the role of mesenchymal stem cell (MSC) in wound healing and tissue regeneration mechanisms in this review, perhaps to send any ideas for a more comprehensive and effective therapy in wound healing.
Regenerative medicine is defined as the process of creating living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage or congenital defects. Because of their extensive ability to self-renew and to generate differentiated progeny, stem cells are the focus of many applications in regenerative medicine. (2, 3, 4) Regenerative medicine is an emerging field with the potential to reduce the need for organ transplantation. It refers to the mechanisms where adult organisms restore form and function to damaged tissues and organs, focusing on three main aspects, each of which has drawbacks. First, the elucidation of mechanistic aspects of embryonic development is crucial to understanding regeneration, however, the field is far from yielding therapeutically applicable outcomes from this knowledge. Second, studying adult tissue turnover and replacement in an evolutionary context, using efficiently regenerating vertebrate species such as fish or salamanders to analyze mechanisms of repair often seems distant from a mammalian perspective and relatively slow to yield mechanistic information. Third, the identification and use of adult and pluripotent stem cells in regenerative medicine has attracted huge scientific and public interest, but until now their clinical application to tissue repair has had minimal impact. Human clinical stem cell therapy studies are being performed and have often utilized autologous stem cells but have not typically focused on modification of the target tissue to optimize their effect. (5) Wounds, both chronic and acute, continue to be a tremendous socioeconomic burden. As such, technologies drawn from many disciplines within science and engineering are constantly being incorporated into innovative wound healing therapies.(6) Healing a wound is, no matter how simple the organization of a cellular system, always the result of sequential steps, where each one taking the damaged area one step closer to restoring cellular architecture and function. (7, 8, 9) If tissue integrity and homeostasis are about to be restored in the moments after an injury occurs, various intracellular and intercellular pathways must be activated and coordinated. Cellular components of the immune system, the blood coagulation cascade and the inflammatory pathways are activated in addition. Many types of cell, including immune cells (neutrophils, monocytes, lymphocytes and dendritic cells), endothelial cells, keratinocytes and fibroblasts, undergo marked changes in gene expression and phenotype, leading to cell proliferation, differentiation and migration. (10, 11) If this response is successful and the injury does not result in the downfall of the organism, these processes must be shut down in a precise sequence in the following days as recovery progresses. (12, 13) For most injuries, repair results in once functional tissue becoming a patch of cell, mainly fibroblasts, and disorganized extracellular matrix (ECM), mainly collagen, which is usually referred to as
The Cell Biology of Regeneration a scar. Surprisingly, in some eukaryotic organisms, the response to injury can perfectly recapitulate the original tissue architecture, through the incompletely understood process of regeneration. Humans have this ability during the prenatal development, but it is lost during adult life. (14) How regeneration occurs and why humans lose this ability remain a mystery. (15) Problems with wound healing mostly manifest in human can be either delayed wound healing (happens a lot in diabetic patients or radiation exposure), or excessive healing resulted in hypertrophic and keloid scars, due to large amounts of ECM deposit and alteration in local vascularization folowed with cell proliferation. This excessive reactions often known as "bad scar". (16) The goal of such research is an ancient one, described in the Greek myth of Prometheus, that is to change wound healing from a process of imperfect repair to complete regeneration. (6) Regeneration of complex structures after injury requires dramatic changes in cellular behavior. Regenerating tissues initiate a program that includes diverse processes such as wound healing, cell death, dedifferentiation, and stem (or progenitor) cell proliferation. Moreover, newly regenerated tissues must integrate polarity and positional identity cues with preexisting body structures. (17) Gene knockdown approaches and transgenesis-based lineage and functional analyses have been instrumental in deciphering various aspects of regenerative processes in diverse animal models for studying regeneration. (9, 17) After amputation, local responses at the site of the wound play important roles in the initiation of regenerative processes. Wound healing, ion flux, and interactions between the wound epidermis and the underlying tissue appear urgently important for regenerative outgrowth. (16, 18) Recent work offers that programmed cell death may play a role in triggering regenerative responses in many different organisms. (19) Apoptotic cells have been observed during early phases of regeneration in several animals that can regenerate missing tissues, for examples planarians, xenopus, and newts. (20) (21) (22) (23) (24) Apoptotic cells have been shown to provide a number of signals that can regulate wound healing and regeneration. Mitogen-activated protein (MAP) kinases signaling through Jun kinase is important both for initiating apoptosis and production of wingless/ integrated (Wnt) and bone morphogenic protein (BMP) mitogens. (25) (26) (27) The further to which these factors are required for stimulating compensatory proliferation remains unclear.
Injury-induced apoptotic signals are also necessary to maintain tissue homeostasis. When cells of the adult Drosophila midgut are injured by toxins or induced to undergo apoptosis, intestinal enterocytes secrete the cytokine. Unpaired, which prompts proliferation of intestinal stem cells through activation of the Jak/Stat pathway. (28) Similarly, in the mouse intestine massive induction of apoptosis via intestine-specific knockout of the p53 inhibitor mouse double minute 2 homolog (Mdm2), it is eventually compensated in adults by increased proliferation and expansion of the stem cell pool. (29) Apoptotic cells also contribute to homeostasis in epithelia by lipid-based signaling, for example sphingosine-1-phosphate, which triggers actomyosin contraction in the surrounding cells, leading to the extrusion of the dying cells.(30) These observations suggest many potential roles for dead and dying cells to alter cell behavior at sites of injury.
New cells can be generated in a sort of ways, including proliferation of a resident stem cell population, division of terminally differentiated cells, or dedifferentiation/ transdifferentiation of mature cells to a stem cell-like precursor or another cell type. The extent to which each mode is used differs between species and even across tissues within the same species. (17) The source of regenerative cells in vertebrates varies between tissues and organisms, and in some cases stays as a matter of continued debate. Mature stem cells contained in many vertebrate tissues play important role in tissue regeneration, turnover and homeostasis in several contexts through the process of division, dedifferentiation, and transdifferentiation. In extreme damage or chronic liver disease, liver progenitor cells appear to be the major sources for new hepatocytes regeneration, while in partial hepatectomy or mild liver injury the liver mass restoration majority accomplished through proliferation of remaining hepatocytes. (31) Similarly, recent lineage-tracing experiments indicate that after damage to the zebrafish heart, the existing cardiomyocytes undergo dedifferentiation and proliferate to generate new cardiomyocytes for replacing lost heart mass. (4, 32, 33) Investigations of model organisms have begun to characterize the cellular sources of regeneration, define their potency, and also identify molecules required for restorative events. Therefore, there is a great opportunity for cell biological studies to link gene function to cellular behavior in the moment. One of the long-term goals of regeneration research is to understand why humans have such limited regenerative potential and what can be done to improve it, if there is any. The knowledge acquired from studying cell biological questions in model organisms should supports turn such future efforts of regenerative medicine.
The capacity to respond to injury and to repair tissue is a fundamental property of all multicellular organisms. But there is astounding diversity in how this process occurs. Studying wound repair in various phyla could improve our understanding of wound repair in humans and might help to identify molecules or pathways that can be targeted to restore the lost regenerative capacity. In general, the wound repair process happens in almost all tissues after exposure to almost any destructive stimulus. Thus, the sequence of events that follows a myocardial infarction (heart attack), for example, is remarkably similar to that following a spinal-cord injury, a burn or a gunshot wound, despite the different types of insult and the different organs affected. Likewise, scar formation which occurred during wound repair leads to similar tissue dysfunction wherever it takes place. In the case of myocardial infarction, the formation of myocardial scar tissue is thought to result in congestive heart failure, a condition in which the heart cannot supply body's tissues with enough blood, and/or abnormal heart rhythms (arrhythmias). (16) Wound healing is an essential biological process that consists of sequential steps aimed at restoring the architecture and function of damaged cells and tissues. (8) Traditionally, mammalian wound healing is described as occurring in three overlapping stages: inflammation, proliferation and remodeling ( Figure 1) . (16) The process of wound healing technically starts at the moment of injury with inflammation. The body's initial response, formation of a fibrin clot, provides hemostasis and recruits several types of cells to the wound. (34) The first circulating immune cells to arrive are neutrophils, with highest concentrations found 1 to 2 days post-injury. They function in preventing bacterial infection (given the disrupted epithelial barrier) as well as in activation of keratinocytes, fibroblasts and immune cells. (34, 35) Early migration of keratinocytes along the temporary fibrin ECM is seen within hours of wounding. (10) Circulating monocytes arrive and differentiate into macrophages 2-3 days after the injury. During the early inflammatory phase of wound healing, macrophages
The Process and Molecular Mechanisms of Wound Healing Completion of re-epithelialization is also attained during the proliferative stage of wound healing. This process involves migration, proliferation and differentiation of keratinocytes drawn from both wound edges and stem cell populations found in the hair follicle bulge region. (38) Despite the participation of stem cells, epidermal appendages are not regenerated during wound healing.(34) Re-epithelialization is aided by the production of a replacement ECM by fibroblasts. Components of the ECM such as fibronectin, along with cytokines such as TGF-β1 and certain inflammatory mediators produced during the immune response to injury, induce fibroblast activation.(39-41) Activated fibroblasts, or myofibroblasts, so named due to the contractile ability provided by their expression of alpha smooth muscle actin (α-SMA), respond physically and biochemically to the mechanical environment of the wound. Physically they contract, adequating to bring the edges of the wound together, decreasing its overall size. (16, 42) They are also responsible for the secretion of the abnormal ECM-characterizing scar tissue. (43) This ECM primarily varies from that of unwounded skin and mature scars in its collagen content, containing increased levels of immature type III collagen, which is relative to the mature type I collagen that predominates in normal skin and mature scar. (6, 43) Comprehensive understanding in normal and pathological wound healing process, either cellular or molecular will provide the possibility for more targeted, efficient therapy development. Knowing the stem cells multipotent and self-renewing properties, along with their low immunogenicity, stem cell application give a positive opportunity for another emerging paradigm for acute and chronic wound treatment. Stem cells from a variety of sources have proven to be successful in experimental wound healing applications, and are now being tested in many preclinical and clinical trials. 
it is uncontrolled and excessive. Immune cells have been identified as key players in this fibrotic cascade, which have the capacity to exert either injury-inducing or repair-promoting effects. A multi-organ approach was recently suggested to identify the core and regulatory pathways in fibrosis, aiming to integrate the wealth of information emerging from basic fibrosis research. (45) Dysfunctional inflammation has also been implicated in hypertrophic scarring. Specifically, hypertrophic scars are related to a prolonged inflammatory phase of wound healing. This may be associated with the mechanism of injury, as they typically occur after burn injury or other trauma to the deep dermis. (46) In contrast, keloid formation is determined by both genetic and environmental factors: they are predominantly seen in darker skinned individuals and the propensity to form them can be inherited. (47, 48) Clinically, both hypertrophic scars and keloids present as pruritic, raised, reddened and firm masses, although a keloid will extend beyond the borders of the original wound.(49) They may be both cosmetically distressing and, due to scar contractures, functionally debilitating.(50,51) While a hypertrophic scars will partially regress (undergo a remodeling phase), a keloid will not. (48) Fibrosis becomes problematic and clinically relevant when dysregulated and excessive scarring occurs in response to persistent injury and drives to altered tissue function. Healing by fibrosis, instead of regeneration, places a huge burden on public health. The total economic cost of diseases which is resulted from fibrosis is difficult to calculate precisely, but it is of the order of tens of billions of dollars.(52) Importantly, dysfunctional healing often causes lifelong disability, which has a significant economic impact.(11) Thus, if fibrotic healing processes can be transformed into regenerative ones, in which the original tissues are restored, this would considerably improve human health.(16) Stem cell-based therapy is one of the most promising therapeutic concepts for wound healing. Advances in stem cell biology have enabled researchers and clinicians alike with access to cells capable of actively modulating the healing response. (6) Macrophages found in all tissues, play a role in tissue development, homeostasis, repair and immunity, known as the most plastic cells in the haematopoeietic system as they show great functional diversity. They are anatomically different from one to another, and have a different transcriptional profiles and functional capabilities, but they are all required for tissue homeostasis maintenance. However, subverted of nay of these reparative and homeostatic functions due to chronic insults, can result in a macrophages associated disease states. (53) Macrophages likely represent the pre-eminent cells in the body endowed with the ability to migrate within tissues, even in hypoxic conditions, and with the capacity to modify the ECM and amplify paracrine signals.
Wound healing is a complex biological process that occurs frequently during adulthood and requires the interplay among different cell types, including keratinocytes, fibroblasts and immune cells. (54) Early studies suggested that macrophages and neutrophils play a crucial role during skin wound healing. Macrophages are generally believed to orchestrate the repair process by acting both as phagocytes, to clear cellular debris, and as a major source of growth factors (e.g., proangiogenic factors, epithelialcell growth factors, etc.). (55) Depletion of macrophages during the subsequent phase of the repair response (tissue formation) caused severe hemorrhage in the wound tissue and prevented tissue maturation and wound closure. Macrophage depletion during the late stage of repair (tissue maturation) did not significantly impact the outcome of the repair response. These interesting observations suggest that macrophages exert distinct functions during the diverse phases of skin repair. In particular, macrophages appear to play an important role in promoting angiogenesis in the granulation tissue during the early phase of skin repair, and in vascular maturation and stabilization in the subsequent phases.(56) Distinct types of wound healing macrophages have been described to date. Their phenotypic and functional characterization is, however, not yet exhaustive. (54) Recruitment of macrophages to the wound healing site may rely on different signals, such as chemokine C-C motif ligand 2 (CCL2)/monocyte chemotactic protein 1 (MCP1), macrophage inflammatory protein-1alpha (MIP1a), but also stromal cell-derived factor 1 (SDF1)/ C-X-C motif chemokine 12 (CXCL12) and granulocytecolony stimulating factor (G-CSF).(57) Okuno and coworkers showed that colony stimulating factor (CSF)-1 is early up-regulated at the wound healing site and play an important role in recruiting macrophages. (58) Thus, wound healing macrophages may exert their proangiogenic programs by physically interacting with sprouting blood vessels, facilitating their growth by degrading the ECM, and/or promoting vascular
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Healing and Tissue Regeneration remodeling via non-canonical (e.g., VEGF-independent) angiogenic pathways. (59) Sindrilaru and co-workers recently reported that human chronic venous ulcers contain increased proportions of macrophages markers (e.g., nitric oxide synthase (NOS)2 and tumor necrosis factor (TNF)-a than healing wounds.(60) Successful mammalian regeneration requires precise coordination of multiple processes, which include scavenging cellular debris, proliferation and activation of progenitor cells, immune modulation, angiogenesis and innervation of the newly forming tissue. (1) Following conditioning by the inflammatory milieu including local growth factors and cytokines, macrophages polarize into classically activated (M1) or alternatively activated (M2) subtypes based on their markers, function, and cytokine profiles. (55) Typically, M1 cells produce high levels of pro-inflammatory cytokines and NOS which aid in host defense but can also damage healthy tissue while M2 macrophages mediate wound healing, tissue repair and the resolution of inflammation. Nevertheless, M1 cells can also have a positive role in tissue regeneration. In the heart and skeletal muscle, early infiltration by M1 macrophages facilitates clearance of necrotic tissue (61, 62) , and disrupting macrophage polarization impairs healing and regeneration, respectively (63) .
Perhaps the strongest link between immune-mediated debris clearance and regenerative capacity has been documented in the central nervous system (CNS) and demyelinating diseases (Figure 2 ). The sensitivity of the CNS to debris clearance may be attributed to the plentiful inhibitory properties of myelin, the membrane sheath that insulates axons, when deposited in damaged tissue. While remyelination is robust in the CNS of young, healthy mice, the ability to restore the myelin sheath declines with age or in disease. Clearance of myelin debris depends on macrophages and recent data suggest that the decline in efficient CNS regeneration is linked to the immune system. (64) Study by Heredia, et al., showed that skeletal muscle regeneration was mediated by interleukin (IL)-4-secreting eosinophils which activating fibro/adipocyte progenitors (FAP) for necessary debris clearance to enhance the effective regeneration. In the absence of IL-4, FAPs do not clear debris, but instead differentiate into adipocytes, which contribute to muscle degeneration ( Figure 2) . (1) In kidney regeneration, macrophage-derived Wnt7b is needed for renal tubular epithelial regeneration. (65) Cross-talk between the immune system and progenitor cell populations mediated by critical modulators of cell to cell signaling such as Notch and Wnt therefore seems to be a generally known regenerative signaling pathway in different tissues. The immune system also affects progenitor and stem cells by creating the appropriate microenvironment for their development and function ( Figure 3) . (1) Both arms of the immune response are required for repair in many systems, for examples in heart, skeletal muscle, and the CNS. If initial, pro-inflammatory signals are not controlled, for example, excessive tissue damage can occur and block repair. Conversely, premature initiation of the anti-inflammatory program can also disrupt efficient tissue healing; for example, skeletal muscle regeneration is impaired when macrophages are prematurely skewed by treatment with IL-10 or genetic loss of MAP kinase phosphatase-1 (MKP-1).(63) Also, in both skeletal muscle regeneration and remyelination, M1 macrophages recruit and stimulate progenitor proliferation while M2 macrophages mediate differentiation, dispelling the common view that M1 macrophage responses are overall bad while M2 are good. (1) The re-establishment of adequate blood flow to injured and newly forming tissue is a key aspect of regeneration. Immune cells help developmental angiogenesis by secreting soluble factors, remodeling matrix and physically pruning and supporting the vasculature during the maturation process. In the developing mouse retina, vessel remodeling is under the control of macrophages via expression of the Wnt ligands Wnt5a and Wnt11 (66) , that enhance the expression of the VEGF inhibitory receptor Fms-Related Tyrosine Kinase 1 (FLT1). Interestingly, genetic disruption of the myeloid non-canonical Wnt pathway can enhance wound angiogenesis and repair, suggesting the same signaling pathway found in the retinal vasculature could have therapeutic applications for modulating myeloid cell signaling to treat wounds. (67) The significance of immune regulation of angiogenesis, progenitor cell activity, debris removal, and appropriate polarization of subsequent immune responses and soluble factor secretion suggests that a closer look at pro-regenerative therapeutics targeted at immunity is warranted.
MSCs are multipotent cells which have the capacity for self-renewal and differentiation and have a wide tissue distribution. These characteristics make them candidate cells for wound healing and regeneration in different kind of disorders. Endogenous and exogenously delivered MSCs can traffic and migrate to injured tissue, participating in tissue healing process. Even the concentrated conditioned medium from MSCs can modulate wound repair without MSCs themselves being present in the tissue. This suggest that MSC therapeutic effects acquired through their ability to differentiate and transdifferentiate into tissue-specific cells, to fuse with the native cells, and to stimulate resident cells survival and functional recovery by secreting a parade of paracrine factors which regulate the local microenvironment (niche) and immune response. (68) MSCs may be obtained from different areas in the body, with the most generally known sources being bone marrow (BM-MSC) and adipose tissue (ASC). While differences in the phenotype of BM-MSCs and ASCs have been observed, both have proven to be efficacious in wound healing therapies. (69) MSC that appears to be a native constituent of the wound bed (70) , have emerged as an alternative to the standard pharmaceutical treatment modalities. These cells are critical trophic mediators to promote tissue regeneration and can be readily derived from a variety of autologous or allogeneic adult tissues, also from commercial providers. (71) The versatility of these cells has made them an attractive candidate for clinical translation in many different therapeutic applications. In particular, MSCs may offer the means of recapitulating several mechanisms which are sufficient for inhibition of scar formation in skin wounds. (72) If the inflammatory phase is prolonged, the proinflammatory mediators will direct the wound healing cells, such as myofibroblasts and fibrocytes, in generating the nonfunctional, void-filling tissue that will result in the formation of a scar. (73) Scars are a consequence of cutaneous wound healing that can be both unsightly and detrimental to the function of the tissue. After the MSCs enter the inflammatory environment, their immunomodulatory phenotype becomes activated by interferon (IFN)-γ, TNF-α and IL-1β. (74) The ability of MSCs to regulate T-cell recruitment, proliferation and activity is well documented. (74, 75) There is also evidence that MSCs are able to suppress the proliferation of B cells (76) and natural killer cells (77) , through ameliorating the acute immune response to injury. By attenuating the function of these cell types, the MSCs would likely reduce the pro-fibrotic responses which can occur coincident with the prolonged inflammation during wound healing. (78, 79) Angiogenesis is an important process during the proliferation phase of wound healing to provide the fibroblasts with sufficient nutrient supply for the production of a provisional granulation matrix.(80) Unsuccessful in generating an adequate microvascular can induce wound closure deficiencies, develop into a chronic non-healing wound. Another important thing is a stable transitional vessels as the tissue remodels and forming a permanent vascular network. MSCs produce basic fibroblast growth factors (FGF) and VEGF-A, in addition to macrophages and fibroblasts, which provide powerful mitogenic cues to promote proliferation, migration and differentiation of microvascular endothelial cells. (81, 82) MSCs also express paracrine factors to promote vascular stability and vasoprotection (83, 84) , including adrenomedullin (85) . It has been hypothesized that these functions are unique to MSCs because of their possible perivascular origin, and they are able to exploit these functions to recreate their perivascular niche as the process of vasculature remodeling is concluded. (86) More interesting and relevant is recent evidence showing that MSCs may transdifferentiate to epidermal cells, keratinocytes and microvascular endothelial cells under defined conditions in vitro. (87) (88) (89) Finally, MSCs may also transdifferentiate into keratinocytes under conditions that allow them to interact with native epidermal cells. (90) These studies suggest that MSCs could participate directly in the structural regeneration of dermal and epidermal tissues, so representing an additional mechanism by which the MSCs may promote cutaneous wound healing. Based on a variety of small and large animal studies, a growing body of evidence finds that MSCs provide significant benefit during dermal wound healing, as they can accelerate the rate of wound closure and re-epithelialization, improve the quality and strength of the regenerated tissue, recover wound healing pathologies that might otherwise result in a chronic, non-healing wound, and minimize the visual appearance of scar tissue. (72) Wound healing is a dynamic process involving complicated interactions between multiple cell types, molecules and the ECM. What limited the development of the effective treatments for wound healing is the incomplete understanding of the pathophysiology of both normal and abnormal wound healing responses. Addition of certain growth factors and cytokines to wounds has resulted in improved wound healing, both in experimental models and clinically. An increasing understanding of stem cell biology has guided to the development of cell-based therapies able to affect multiple aspects of wound healing. Stem cell therapies hold huge promise as we continue to search for ways to regenerate damaged tissues. As our knowledge continues to improve, emerging technologies will allow for the development of safe, specialized wound therapies recreating the physical and chemical properties of the stem cell niche, potentially allowing for tissue regeneration as opposed to repair.
Conclusion

